Access the full text.
Sign up today, get DeepDyve free for 14 days.
Atsushi Kiba, H. Sagara, T. Hara, M. Shibuya (2003)
VEGFR-2-specific ligand VEGF-E induces non-edematous hyper-vascularization in mice.Biochemical and biophysical research communications, 301 2
T. Bensaoula, Anna Ottlecz (2001)
Biochemical and ultrastructural studies in the neural retina and retinal pigment epithelium of STZ-diabetic rats: effect of captopril.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 17 6
R. Masood, Jie Cai, T. Zheng, D. Smith, Y. Naidu, P. Gill (1997)
Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma.Proceedings of the National Academy of Sciences of the United States of America, 94 3
Neela Patel, Li Sun, D. Moshinsky, Hui Chen, K. Leahy, Phuong Le, K. Moss, Xueyan Wang, A. Rice, D. Tam, A. Laird, Xiaoming Yu, Qingling Zhang, C. Tang, G. Mcmahon, A. Howlett (2003)
A Selective and Oral Small Molecule Inhibitor of Vascular Epithelial Growth Factor Receptor (VEGFR)-2 and VEGFR-1 Inhibits Neovascularization and Vascular PermeabilityJournal of Pharmacology and Experimental Therapeutics, 306
K. Dunn, A. Aotaki-Keen, F. Putkey, L. Hjelmeland (1996)
ARPE-19, a human retinal pigment epithelial cell line with differentiated properties.Experimental eye research, 62 2
T. Otani, S. Kishi, Y. Maruyama (1999)
Patterns of diabetic macular edema with optical coherence tomography.American journal of ophthalmology, 127 6
D. Antonetti, A. Barber, S. Khin, E. Lieth, J. Tarbell, T. Gardner (1998)
Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group.Diabetes, 47 12
P. Hofman, H. Blaauwgeers, M. Tolentino, A. Adamis, B. Cardozo, G. Vrensen, R. Schlingemann (2000)
VEGF-A induced hyperpermeability of blood-retinal barrier endothelium in vivo is predominantly associated with pinocytotic vesicular transport and not with formation of fenestrations. Vascular endothelial growth factor-A.Current eye research, 21 2
A. Khaliq, D. Foreman, A. Ahmed, H. Weich, Z. Gregor, D. McLeod, M. Boulton (1998)
Increased expression of placenta growth factor in proliferative diabetic retinopathy.Laboratory investigation; a journal of technical methods and pathology, 78 1
J. Butler, Steven Guthrie, M. Koç, A. Afzal, S. Caballero, H. Brooks, R. Mames, M. Segal, M. Grant, E. Scott (2005)
SDF-1 is both necessary and sufficient to promote proliferative retinopathy.The Journal of clinical investigation, 115 1
A. Witmer, G. Vrensen, C. Noorden, R. Schlingemann (2003)
Vascular endothelial growth factors and angiogenesis in eye diseaseProgress in Retinal and Eye Research, 22
H. Gerber, F. Condorelli, Jeanie Park, N. Ferrara (1997)
Differential Transcriptional Regulation of the Two Vascular Endothelial Growth Factor Receptor GenesThe Journal of Biological Chemistry, 272
V. Poulaki, A. Joussen, N. Mitsiades, C. Mitsiades, E. Iliaki, A. Adamis (2004)
Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy.The American journal of pathology, 165 2
B. Fu, S. Shen (2003)
Structural mechanisms of acute VEGF effect on microvessel permeability.American journal of physiology. Heart and circulatory physiology, 284 6
D. Antonetti, A. Barber, Leigh Hollinger, E. Wolpert, T. Gardner (1999)
Vascular Endothelial Growth Factor Induces Rapid Phosphorylation of Tight Junction Proteins Occludin and Zonula Occluden 1The Journal of Biological Chemistry, 274
J. Piret, D. Mottet, M. Raes, C. Michiels (2002)
CoCl2, a Chemical Inducer of Hypoxia‐Inducible Factor‐1, and Hypoxia Reduce Apoptotic Cell Death in Hepatoma Cell Line HepG2Annals of the New York Academy of Sciences, 973
P. Hofman, H. Blaauwgeers, M. Tolentino, A. Adamis, B. Cardozo, G. Vrensen, R. Schlingemann (2000)
VEGF-A induced hyperpermeability of blood-retinal barrier endothelium in vivo is predominantly associated with pinocytotic vesicular transport and not with formation of fenestrationsCurrent Eye Research, 21
G. Amerongen, V. Hinsbergh (2002)
Targets for pharmacological intervention of endothelial hyperpermeability and barrier function.Vascular pharmacology, 39 4-5
M. Grant, A. Afzal, P. Spoerri, Hao Pan, L. Shaw, R. Mames (2004)
The role of growth factors in the pathogenesis of diabetic retinopathyExpert Opinion on Investigational Drugs, 13
A. Meleth, E. Agrón, C. Chan, G. Reed, K. Arora, G. Byrnes, K. Csaky, F. Ferris, E. Chew (2005)
Serum inflammatory markers in diabetic retinopathy.Investigative ophthalmology & visual science, 46 11
H. Christinger, G. Fuh, A. Vos, C. Wiesmann (2004)
The Crystal Structure of Placental Growth Factor in Complex with Domain 2 of Vascular Endothelial Growth Factor Receptor-1*Journal of Biological Chemistry, 279
Jean-Marie Rakic, Vincent Lambert, L. Devy, A. Luttun, P. Carmeliet, Carel Claes, Laurent Nguyen, J. Foidart, Agnès Noël, C. Munaut (2003)
Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization.Investigative ophthalmology & visual science, 44 7
E. Cunningham, A. Adamis, M. Altaweel, L. Aiello, N. Bressler, D. D’Amico, M. Goldbaum, D. Guyer, B. Katz, Manju Patel, S. Schwartz (2005)
A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema.Ophthalmology, 112 10
M. Tjwa, A. Luttun, M. Autiero, P. Carmeliet (2003)
VEGF and PlGF: two pleiotropic growth factors with distinct roles in development and homeostasisCell and Tissue Research, 314
S Lightman, HM Towler (2003)
Diabetic retinopathyClin Cornerstone, 5
Hiroyuki Takahashi, S. Hattori, A. Iwamatsu, H. Takizawa, M. Shibuya (2004)
A Novel Snake Venom Vascular Endothelial Growth Factor (VEGF) Predominantly Induces Vascular Permeability through Preferential Signaling via VEGF Receptor-1*Journal of Biological Chemistry, 279
R. Caldwell, M. Bartoli, M. Behzadian, A. El-Remessy, M. Al-Shabrawey, D. Platt, R. Caldwell (2003)
Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectivesDiabetes/Metabolism Research and Reviews, 19
T. Sano, N. Hotta (2001)
[Diabetic retinopathy].Nihon rinsho. Japanese journal of clinical medicine, 59 Suppl 8
DA Antonetti, AJ Barber, S Khin, E Lieth, JM Tarbell, TW Gardner (1998)
Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cellsDiabetes, 47
K. Ohno-Matsui, Takeshi Yoshida, T. Uetama, M. Mochizuki, I. Morita (2003)
Vascular endothelial growth factor upregulates pigment epithelium-derived factor expression via VEGFR-1 in human retinal pigment epithelial cells.Biochemical and biophysical research communications, 303 3
M. Autiero, A. Luttun, M. Tjwa, P. Carmeliet (2003)
Placental growth factor and its receptor, vascular endothelial growth factor receptor‐1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disordersJournal of Thrombosis and Haemostasis, 1
H. Ozdemir, M. Karaçorlu, S. Karacorlu (2005)
Serous macular detachment in diabetic cystoid macular oedema.Acta ophthalmologica Scandinavica, 83 1
N. Markomichelakis, I. Halkiadakis, Eugenia Pantelia, V. Peponis, A. Patelis, P. Theodossiadis, G. Theodossiadis (2004)
Patterns of macular edema in patients with uveitis: qualitative and quantitative assessment using optical coherence tomography.Ophthalmology, 111 5
F. Fan, J. Wey, M. McCarty, A. Belcheva, Wenbiao Liu, T. Bauer, R. Somcio, Yan Wu, A. Hooper, D. Hicklin, L. Ellis (2005)
Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cellsOncogene, 24
HP Gerber, F Condorelli, J Park, N Ferrara (1997)
Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxiaJ Biol Chem, 272
DA Antonetti, AJ Barber, LA Hollinger, EB Wolpert, TW Gardner (1999)
Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occludens 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumorsJ Biol Chem, 274
P. Campochiaro (2000)
Retinal and choroidal neovascularizationJournal of Cellular Physiology, 184
Our results indicate that PLGF-1 may be a potential regulation target for the control of diabetic retinal and macular oedema.
Diabetologia – Springer Journals
Published: Feb 1, 2007
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.